News | April 01, 2022
Sumitomo Chemical to build new API and intermediates plant in Japan
The plant is scheduled to come on stream in September 2024
The plant is scheduled to come on stream in September 2024
The fund has already invested in seven companies including Medikabazaar, THB, Impact Guru, Stanplus, Ekincare, Qure.ai and HealthifyMe
Technology Development Board supports commercialisation of Metal Injection Molding of implants
New collaboration will help customers reach sustainability goals for high-performance Udel PSU polymers in demanding applications.
The company’s differentiated value proposition comes during a time of unprecedented disruption in the life science supply chain
It celebrated its 100th session as LPC-100 in association with Mundial Pharma
The Congress gathers pharmaceutical companies, CMOs and CDMOs, governmental bodies together with pharmaceutical equipment providers and service companies
The next-gen logistics management solutions are making the global supply chains more customer-centric and sustainable
This collaboration strengthens Akron’s portfolio of off-the-shelf gene-editing technologies while broadening Vor Bio’s collection of nucleases to engineer gene-modified cell therapies
Saransh Chaudhary, President, Global Critical Care Division, Venus Remedies and CEO, Venus Medicine Research Centre In conversation with Thomas C Thottathil, Editor, www.indianpharmapost.com identified key areas that the company is focusing on in its Mission 2025
Subscribe To Our Newsletter & Stay Updated
